The DOI matches its Crossref record; 32 of the 32 references it cites were found in a registry or an index.
Big data from electronic health records for early and late translational cardiovascular research: challenges and potential
Open accessAbstract
Aims: Cohorts of millions of people's health records, whole genome sequencing, imaging, sensor, societal and publicly available data present a rapidly expanding digital trace of health. We aimed to critically review, for the first time, the challenges and potential of big data across early and late stages of translational cardiovascular disease research. Methods and results: We sought exemplars based on literature reviews and expertise across the BigData@Heart Consortium. We identified formidable challenges including: data quality, knowing what data exist, the legal and ethical framework for their use, data sharing, building and maintaining public trust, developing standards for defining disease, developing tools for scalable, replicable science and equipping the clinical and scientific work force with new inter-disciplinary skills. Opportunities claimed for big health record data include: richer profiles of health and disease from birth to death and from the molecular to the societal scale; accelerated understanding of disease causation and progression, discovery of new mechanisms and treatment-relevant disease sub-phenotypes, understanding health and diseases in whole populations and whole health systems and returning actionable feedback loops to improve (and potentially disrupt) existing models of research and care, with greater efficiency. In early translational research we identified exemplars including: discovery of fundamental biological processes e.g. linking exome sequences to lifelong electronic health records (EHR) (e.g. human knockout experiments); drug development: genomic approaches to drug target validation; precision medicine: e.g. DNA integrated into hospital EHR for pre-emptive pharmacogenomics. In late translational research we identified exemplars including: learning health systems with outcome trials integrated into clinical care; citizen driven health with 24/7 multi-parameter patient monitoring to improve outcomes and population-based linkages of multiple EHR sources for higher resolution clinical epidemiology and public health. Conclusion: High volumes of inherently diverse ('big') EHR data are beginning to disrupt the nature of cardiovascular research and care. Such big data have the potential to improve our understanding of disease causation and classification relevant for early translation and to contribute actionable analytics to improve health and healthcare.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Sudlow, C., Gallacher, J., Allen, N., Beral, V., Burton, P., Danesh, J., Downey, P., Elliott, P., Green, J., Landray, M., et al. (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001779 · Cited by 12,728
Self-citationBarnett, K., Mercer, S. W., Norbury, M., Watt, G., Wyke, S., & Guthrie, B. (2012) · The Lancet · doi:10.1016/s0140-6736(12)60240-2 · Cited by 6,972
Benchimol, E. I., Smeeth, L., Guttmann, A., Harron, K., Moher, D., Petersen, I., Sørensen, H. T., von Elm, E., Langan, S. M., & RECORD Working Committee (2015) · PLOS Medicine · doi:10.1371/journal.pmed.1001885 · Cited by 5,749
The Spread of Obesity in a Large Social Network over 32 Years
Christakis, N. A., & Fowler, J. H. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa066082 · Cited by 5,007
Sequence Variations in PCSK9, Low LDL, and Protection against Coronary Heart Disease
Cohen, J. C., Boerwinkle, E., Mosley, T. H., & Hobbs, H. H. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa054013 · Cited by 3,181
Effects of torcetrapib in patients at high risk for coronary events
Barter, P. J., Caulfield, M., Eriksson, M., Grundy, S. M., Kastelein, J. J. P., Komajda, M., Lopez-Sendon, J., Mosca, L., Tardif, J.-C., Waters, D. D., et al. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa0706628 · Cited by 3,139
Explaining the decrease in U.S. deaths from coronary disease, 1980–2000
Ford, E. S., Ajani, U. A., Croft, J. B., Critchley, J. A., Labarthe, D. R., Kottke, T. E., Giles, W. H., & Capewell, S. (2007) · New England Journal of Medicine · doi:10.1056/nejmsa053935 · Cited by 2,757
The Parable of Google Flu: Traps in Big Data Analysis
Lazer, D., Kennedy, R., King, G., & Vespignani, A. (2014) · Science · doi:10.1126/science.1248506 · Cited by 2,523 · cited 2×
“…content in social media are inherently public and the language used in twitter can be used to predict community heart disease rates ( Table 2 , Eichstaedt et al. 23 ) and it is plausible that Google searches 24 might give clues to environmental pollution triggers of acute cardiovascular events.”
BackgroundThe collective dynamics of smoking in a large social network
Christakis, N. A., & Fowler, J. H. (2008) · New England Journal of Medicine · doi:10.1056/nejmsa0706154 · Cited by 2,390
Effects of dalcetrapib in patients with a recent acute coronary syndrome
Schwartz, G. G., Olsson, A. G., Abt, M., Ballantyne, C. M., Barter, P. J., Brumm, J., Chaitman, B. R., Holme, I. M., Kallend, D., Leiter, L. A., et al. (2012) · New England Journal of Medicine · doi:10.1056/nejmoa1206797 · Cited by 2,022
Cited by
Effect of systolic and diastolic blood pressure on cardiovascular outcomes
Flint, A. C., Conell, C., Ren, X., Banki, N. M., Chan, S. L., Rao, V. A., Melles, R. B., & Bhatt, D. L. (2019) · New England Journal of Medicine · doi:10.1056/nejmoa1803180 · Cited by 684
From Big Data to Precision Medicine
Hulsen, T., Jamuar, S. S., Moody, A. R., Karnes, J. H., Varga, O., Hedensted, S., Spreafico, R., Hafler, D. A., & McKinney, E. F. (2019) · Frontiers in Medicine · doi:10.3389/fmed.2019.00034 · Cited by 459
Avoidable flaws in observational analyses: an application to statins and cancer
Dickerman, B. A., García-Albéniz, X., Logan, R. W., Denaxas, S., & Hernán, M. A. (2019) · Nature Medicine · doi:10.1038/s41591-019-0597-x · Cited by 308
Self-citationKalkman, S., van Delden, J., Banerjee, A., Tyl, B., Mostert, M., & van Thiel, G. (2022) · Journal of Medical Ethics · doi:10.1136/medethics-2019-105651 · Cited by 292
Self-citationLongevity leap: mind the healthspan gap
Garmany, A., Yamada, S., & Terzic, A. (2021) · npj Regenerative Medicine · doi:10.1038/s41536-021-00169-5 · Cited by 252
Metadata
- Authors
- Hemingway, H., Asselbergs, F. W., Danesh, J., Dobson, R., Maniadakis, N., Maggioni, A., van Thiel, G. J. M., Cronin, M., Brobert, G., Vardas, P., Anker, S. D., Grobbee, D. E., Denaxas, S., & Innovative Medicines Initiative 2nd programme, B. D. F. B. O.
- Venue
- European Heart Journal
- Publisher
- Oxford University Press (OUP)
- Published
- 2017-08-29
- Volume
- 39
- Issue
- 16
- Pages
- 1481-1495
- ISSN
- 0195-668X (ISSN-L)
- 1522-9645
- OpenAlex
- W2790916396
- Cited by
- 209
- References
- 32
- FWCI
- 27.04
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Big data from electronic health records for early and late translational cardiovascular research: challenges and potential. https://app.cochat.ai/papers/10.1093/eurheartj/ehx487
- The paper
- Hemingway, H., Asselbergs, F. W., Danesh, J., Dobson, R., Maniadakis, N., Maggioni, A., van Thiel, G. J. M., Cronin, M., Brobert, G., Vardas, P., Anker, S. D., Grobbee, D. E., Denaxas, S., & Innovative Medicines Initiative 2nd programme, B. D. F. B. O. (2018). Big data from electronic health records for early and late translational cardiovascular research: challenges and potential. European Heart Journal. https://doi.org/10.1093/eurheartj/ehx487
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.